2 months Boston Scientific profit beats estimates as cardiovascular sales surge MarketWatch
Sales of the Marlborough, Mass. company’s cardiovascular products rose 17.8% to $2.64 billion.
Boston · Boston Scientific (BSX)
Sales of the Marlborough, Mass. company’s cardiovascular products rose 17.8% to $2.64 billion.
Boston · Boston Scientific (BSX)